Artificial Intelligence ECG as a Novel Screening Tool to Detect a Newly Abnormal Left Ventricular Ejection Fraction After Anthracycline-Based Cancer Therapy.
Johanna E J JacobsGrace GreasonKathryn E MangoldHans P M W WildiersRik WillemsStefan P JanssensPeter NoseworthyFrancisco Lopez-JimenezJens Uwe VoigtPaul FriedmanLucas Van AelstBert VandenberkZachi Itzhak AttiaJoerg HerrmannPublished in: European journal of preventive cardiology (2023)
These data support the use of AI-ECG for cardiotoxicity screening after anthracycline-based chemotherapy. This technology could serve as a gatekeeper to more costly cardiac imaging and could enable patients to monitor themselves over long periods of time.
Keyphrases
- ejection fraction
- artificial intelligence
- aortic stenosis
- left ventricular
- big data
- machine learning
- cancer therapy
- deep learning
- heart rate variability
- drug delivery
- high resolution
- newly diagnosed
- heart failure
- squamous cell carcinoma
- electronic health record
- hypertrophic cardiomyopathy
- mitral valve
- transcatheter aortic valve replacement
- rectal cancer
- mass spectrometry
- cardiac resynchronization therapy
- fluorescence imaging